Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Exscientia Ltd ADR
(NQ:
EXAI
)
4.170
-0.210 (-4.79%)
Streaming Delayed Price
Updated: 1:25 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
232,036
Open
4.400
Bid (Size)
4.170 (4)
Ask (Size)
4.190 (10)
Prev. Close
4.380
Today's Range
4.130 - 4.400
52wk Range
4.140 - 9.100
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The 10 Stocks In The Clinical-Stage BioTech Drug Stocks Index Are Down 4% YTD
April 15, 2024
The pharmaceutical industry is embracing AI to streamline drug discovery and researching the use of psychedelic compound-based ingredients for the treatment of, as yet, untreatable diseases.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 03, 2024
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly...
Via
Benzinga
Exposures
Glyphosate
Performance
YTD
-33.33%
-33.33%
1 Month
-29.80%
-29.80%
3 Month
-31.75%
-31.75%
6 Month
-27.35%
-27.35%
1 Year
-18.71%
-18.71%
More News
Read More
Exscientia Earnings Preview
March 20, 2024
Via
Benzinga
Six Of Seven AI Stock Categories Increased This Week
March 23, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
EXAI Stock Earnings: Exscientia Misses EPS, Misses Revenue for Q4 2023
March 21, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 21, 2024
Via
Benzinga
Exscientia Business and Financial Update for the Full Year 2023
March 21, 2024
From
Exscientia plc
Via
Business Wire
Earnings Scheduled For March 21, 2024
March 21, 2024
Via
Benzinga
Exscientia to Report Full Year 2023 Financial Results on March 21, 2024
March 14, 2024
From
Exscientia plc
Via
Business Wire
The Top 3 Healthcare Stocks to Buy on Weakness in 2024
March 04, 2024
Via
InvestorPlace
AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD
March 04, 2024
Via
Talk Markets
Exscientia to Present at Upcoming Investor Conferences in March
February 28, 2024
From
Exscientia plc
Via
Business Wire
Exscientia plc (EXAI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
February 26, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics
February 19, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AI Drug Hunter Firm Exscientia Fires Its CEO Over 'Inappropriate' Relationships with Two Employees
February 13, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 13, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 12, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
February 12, 2024
Via
InvestorPlace
Exscientia Initiates Clinical Study to Further Evaluate Functional Precision Medicine Platform in Cancer Patients
February 07, 2024
From
Exscientia plc
Via
Business Wire
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 10, 2024
Via
Benzinga
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 05, 2024
Via
Benzinga
M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024
January 02, 2024
Via
InvestorPlace
Professor Andrew L. Hopkins appointed Commander of the Order of the British Empire (CBE)
January 02, 2024
From
Exscientia
Via
Business Wire
Top Picks 2024: Exscientia Plc
December 31, 2023
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AI-Focused Drug Discovery Stocks Index Up 26% In December
December 29, 2023
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.